Clinical Trials Directory

Trials / Completed

CompletedNCT07195396

To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake

A Randomized, Double-blind, Moncentric, Cross-over Study to Collect Human Serum After Ingestion of Hydrolyzed Collagen Peptides.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Rousselot BVBA · Industry
Sex
Female
Age
35 Years – 45 Years
Healthy volunteers
Accepted

Summary

This randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblasts, and other cell types to explore the beneficial effects of bioactive collagen peptides. Blood will also be analyzed for amino acid profiles and collagen-derived peptides.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCollagen hydrolysate 110g single oral dose dissolved in water
DIETARY_SUPPLEMENTCollagen hydrolysate 210g single oral dose dissolved in water
DIETARY_SUPPLEMENTCollagen hydrolysate 310g single oral dose dissolved in water
DIETARY_SUPPLEMENTCollagen hydrolysate 410g single oral dose dissolved in water
DIETARY_SUPPLEMENTCollagen hydrolysate 510g single oral dose dissolved in water

Timeline

Start date
2025-10-22
Primary completion
2025-12-22
Completion
2025-12-22
First posted
2025-09-26
Last updated
2026-01-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07195396. Inclusion in this directory is not an endorsement.